2022 Vaccines for Adults (VFA)
Closed Solicitation Posted
This opportunity was awarded. See its 6 award notices in the notice history.
- Solicitation number
- 75D301-22-R-72159
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC), through its National Center for Immunization and Respiratory Diseases, seeks to award indefinite-delivery, indefinite-quantity contracts to purchase 12 standard adult vaccines. The solicitation requires minimum and maximum order quantities ranging from 100 to 1,000,000 doses for each vaccine. Deliveries must occur within 15 business days of order and vaccines must have a minimum 12-month shelf life. Offers are due by March 14, 2022 and the resulting contracts will have a one year period of performance from July 1, 2022 to June 30, 2023. The evaluation criteria and basis for award are in accordance with FAR Parts 12 and 15. All inquiries must be submitted in writing by March 7.
There is no set-aside designation for this procurement. The solicitation involves NAICS code 325414 and PSC code 6515 for pharmaceutical preparations. The vaccines will support CDC immunization awardees including state health departments in their adult immunization programs as authorized under Section 317(j) of the Public Health Service Act. The place of performance is within the United States.
Notice text
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite-delivery, indefinite-quantity contracts for the purchase of the following adult vaccines, at the estimated quantities listed, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration.
Hepatitis A adult vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 1,000,000 Doses
Minimum: 100 Doses
Hepatitis B adult vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 750,000 Doses
Minimum: 100 Doses
Hepatitis A & B combination adult vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 275,000 Doses
Minimum: 100 Doses
Pneumococcal Polysaccharide vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses
Tetanus and Diphtheria Toxoids vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100,000 Doses
Minimum: 100 Doses
Herpes Zoster vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 Doses
Minimum: 100 Doses
Tetanus, Reduced Diphtheria Toxoid, and Acellular Pertussis (TDaP) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 850,000 Doses
Minimum: 100 Doses
Measles, Mumps, and Rubella vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 250,000 Doses
Minimum: 100 Doses
Meningococcal Conjugate (Groups A,C,Y &W) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses
Human Papillomavirus types vaccine (HPV9)
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 300,000 Doses
Minimum: 100 Doses
Varicella vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 150,000 Doses
Minimum: 10 Doses
Pneumococcal Conjugate (PCV) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 500,000 Doses
Minimum: 100 Doses
Serogroup B Meningococcal
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 200,000 Doses
Minimum: 100 Doses
All vaccines are required to be delivered within 15 business days after receipt of order. Vaccines shall be shipped F.O.B. destination, as directed by delivery orders. The period of performance shall be July 1, 2022 through June 30, 2023.
The vaccines awarded under these contracts will be purchased for NCIRD's immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult
immunization programs as provided under Section 317(j) of the Public Health Service Act.
This acquisition is being conducted in accordance with FAR Part 12 and Part 15 procedures. Please find the solicitation attached to this notice.
Offers shall be submitted by 5:00 PM Eastern Standard Time (EST) on March 14, 2022.
Any inquiries regarding this solicitation shall be submitted in writing to Brian Swann at qty0@cdc.gov and Pellumbeshe Hoxhaj at kfx2@cdc.gov no later than March 7, 2022 at 5:00 PM EST. Telephone inquiries will not be honored.
Attachments
| File | Type | Posted |
|---|---|---|
| 2022 Vaccines for Adults - Solicitation.doc | DOC document | |
| 2022 Vaccines for Adults - Solicitation.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 2022 Vaccines for Adults (VFA) | Award Notice | |
| 2022 Vaccines for Adults (VFA) | Award Notice | |
| 2022 Vaccines for Adults (VFA) | Award Notice | |
| 2022 Vaccines for Adults (VFA) | Solicitation |
And 3 more award notices.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity